{"id":46794,"date":"2022-08-01T15:01:58","date_gmt":"2022-08-01T13:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/braincheck-launches-investigator-initiated-research-iir-grant-program-for-brain-and-cognitive-disorders-research\/"},"modified":"2022-08-01T15:01:58","modified_gmt":"2022-08-01T13:01:58","slug":"braincheck-launches-investigator-initiated-research-iir-grant-program-for-brain-and-cognitive-disorders-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/braincheck-launches-investigator-initiated-research-iir-grant-program-for-brain-and-cognitive-disorders-research\/","title":{"rendered":"BrainCheck Launches Investigator Initiated Research (IIR) Grant Program For Brain and Cognitive Disorders Research"},"content":{"rendered":"
\n

\nThe BrainCheck IIR Grant is looking to fund research that aids in the early detection and treatment of patient pools experiencing cognitive decline.<\/i>\n<\/p>\n

SAN DIEGO–(BUSINESS WIRE)–BrainCheck <\/a>Inc.<\/a>, developer of an innovative digital cognitive assessment and care platform, today announced an Investigator Initiated Research (IIR) Grant Program to help fund research for evaluation, diagnosis, treatment and care for brain related disease. This includes, but is not limited to, Alzheimer’s disease and related dementias (ADRD), post-operative delirium, stroke, traumatic brain injury, and post-acute Covid \u201cbrain fog\u201d. Awardees will be provided one-year research funding and free access to the BrainCheck platform.\n<\/p>\n

<\/a><\/p>\n

\nThe BrainCheck IIR Grant Program will fund up to two projects, and awards are for up to $5,000 (in total direct costs) budgeted over a maximum of 12 months and are non-renewable. Applications will open July 28, 2022 and will close October 15, 2022.\n<\/p>\n

\nWinners will then be notified by November 15, 2022 and will also be awarded with:\n<\/p>\n